OverviewChartNewsTraderScreen

Erste Bank Bonus Zert 1FC 28.06.2.../  AT0000A36Z42  /

Wien SP
2024-05-17  5:25:00 PM Chg.0.00 Bid5:25:00 PM Ask5:25:00 PM Underlying Strike price Expiration date Option type
6.45EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 FACC AG INH.AKT. - EUR 2024-06-28 Call
GlobeNewswire 05-17 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
GlobeNewswire 05-17 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...
GlobeNewswire 05-16 CVRx Announces Key Senior Leadership Team Hires
GlobeNewswire 05-15 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire 05-15 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...
GlobeNewswire 05-07 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...
GlobeNewswire 05-07 Rugby Provides Exploration Update on its Gold-Silver Projects in  Santa Cruz Province, Argentina
GlobeNewswire 05-02 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...
GlobeNewswire 04-30 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire 04-23 Clinical ink announces GlucoseReady™
GlobeNewswire 04-08 Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire 04-07 Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire 04-01 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire 03-27 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire 03-25 Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire 03-25 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire 03-13 Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire 03-12 HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire 02-27 Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire 02-26 HeartSciences Adds Key Advisor to its Scientific Advisory Board
GlobeNewswire 02-22 RAJANT HEALTH’S CUTTING-EDGE WEARABLE RECEIVES MEDICAL EXPERT ENDORSEMENTS
GlobeNewswire 02-20 Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...
GlobeNewswire 02-09 Inteleos Announces 2024 Board of Directors
GlobeNewswire 02-07 Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...
GlobeNewswire 01-29 Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...